Okazawa H - Search Results

1

Clinical impact of hemodynamic parameter measurement for cerebrovascular disease using positron emission tomography and (15)O-labeled tracers.

Okazawa H, Kudo T. Okazawa H, et al. Ann Nucl Med. 2009 May;23(3):217-27. doi: 10.1007/s12149-009-0235-7. Epub 2009 Apr 8. Ann Nucl Med. 2009. PMID: 19353235 Review.

2

Clinical application of 62Zn/62Cu positron generator: perfusion and plasma pool images in normal subjects.

Okazawa H, Fujibayashi Y, Yonekura Y, Tamaki N, Nishizawa S, Magata Y, Ishizu K, Tsuchida T, Sadato N, Konishi J, et al. Okazawa H, et al. Ann Nucl Med. 1995 May;9(2):81-7. doi: 10.1007/BF03164971. Ann Nucl Med. 1995. PMID: 7662494

3

Optimal dose of injection in activation study with O-15 water and PET.

Sadato N, Yonekura Y, Magata Y, Nishizawa S, Ishizu K, Okazawa H, Tsuchida T, Tanaka F, Tamaki N, Sasayama S, et al. Sadato N, et al. Among authors: okazawa h. Ann Nucl Med. 1994 Nov;8(4):239-43. doi: 10.1007/BF03165026. Ann Nucl Med. 1994. PMID: 7702968

4

Simplified quantification of regional cerebral blood flow with 99mTc-ECD SPECT and continuous arterial blood sampling.

Yonekura Y, Ishizu K, Okazawa H, Tanaka F, Hattori N, Sadato N, Tsuchida T, Nishizawa S, Tamaki N, Nagamine T, Konishi J, Shibasaki H. Yonekura Y, et al. Among authors: okazawa h. Ann Nucl Med. 1996 May;10(2):177-83. doi: 10.1007/BF03165390. Ann Nucl Med. 1996. PMID: 8800446

5

Measurement of regional cerebral plasma pool and hematocrit with copper-62-labeled HSA-DTS.

Okazawa H, Yonekura Y, Fujibayashi Y, Yamauchi H, Ishizu K, Nishizawa S, Magata Y, Tamaki N, Fukuyama H, Yokoyama A, Konishi J. Okazawa H, et al. J Nucl Med. 1996 Jul;37(7):1080-5. J Nucl Med. 1996. PMID: 8965173 Free article.

6

Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.

Okazawa H, Yonekura Y, Fujibayashi Y, Mukai T, Nishizawa S, Magata Y, Ishizu K, Tamaki N, Konishi J. Okazawa H, et al. J Nucl Med. 1996 Jul;37(7):1089-93. J Nucl Med. 1996. PMID: 8965175 Free article.

7

Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.

Okazawa H, Yamauchi H, Sugimoto K, Takahashi M. Okazawa H, et al. J Nucl Med. 2003 Sep;44(9):1371-8. J Nucl Med. 2003. PMID: 12960179 Free article. Clinical Trial.

8

Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.

Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. Okazawa H, et al. J Nucl Med. 2003 Dec;44(12):1875-83. J Nucl Med. 2003. PMID: 14660711 Free article. Clinical Trial.

9

Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan.

Ito H, Kanno I, Kato C, Sasaki T, Ishii K, Ouchi Y, Iida A, Okazawa H, Hayashida K, Tsuyuguchi N, Ishii K, Kuwabara Y, Senda M. Ito H, et al. Among authors: okazawa h. Eur J Nucl Med Mol Imaging. 2004 May;31(5):635-43. doi: 10.1007/s00259-003-1430-8. Epub 2004 Jan 17. Eur J Nucl Med Mol Imaging. 2004. PMID: 14730405 Clinical Trial.

10

Effects of metabolite correction for arterial input function on quantitative receptor images with 11C-flumazenil in clinical positron emission tomography studies.

Okazawa H, Yamauchi H, Sugimoto K, Magata Y, Kudo T, Yonekura Y. Okazawa H, et al. J Comput Assist Tomogr. 2004 May-Jun;28(3):428-35. doi: 10.1097/00004728-200405000-00021. J Comput Assist Tomogr. 2004. PMID: 15100552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters